Epidural Dexamethasone Versus Betamethasone for Treatment of Lumbosacral Radiculalgia
Unknown statusPhase 4NCT02833116
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study evaluate the administration of epidural betamethasone versus dexamethasone for pain reduction, consumption of analgesic and quality of life. Half of the patient will receive dexametasone and the other half betametasone.
Study details
- Official title
- Efficacy and Safety of Dexamethasone Versus Betamethasone Epidural Caudal Administration for Treatment of Lumbosacral Radiculalgia: Randomized Clinical Trial
- Conditions
- Interventions
- Drug: Betamethasone
- Drug: Dexamethasone
- Sponsor
- Basque Health Service
- Start date
- 2016-06
- Primary completion
- 2018-06
- Sex
- All
- Age range
- from 18 Years to 80 Years
- Results posted
- No results posted in this snapshot
- Countries
- Spain
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Unilateral leg pain secondary to lateral stenosis, disc protrusion or herniated disc. * Age between 18 and 80 years. * Moderate to severe pain (NVS\>4). * Right proficient oral and written language. Exclusion Criteria: * Patients with high intracranial pressure. * Patients with Multiple Sclerosis. * Patients with Guillain-Barré syndrome radiculopathy of vascular origin. * Patients with previous lumbar surgery. * Patients pregnant or lactating. * Patients with allergy or intolerance to any of the drugs used. * Patients with severe cognitive impairment. * Patients with intrathecal injectio radiculalgia. * Patients with poorly controlled major psychiatric pathology. * Patients with type I diabetes or poorly controlled type II diabetes (Hb1Ac\>8.5). * Patients with glaucoma. * Patients with caudal equine syndrome. * Patients with pre-treatment with steroid injections/or local anesthetics. * Patients with central canal stenosis. * patients with chronic treatment with oral corticosteroids without stabilized pattern.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02833116